Research & Development
ATS, IDSA revamp pneumonia testing guidance
The new recommendations apply to the diagnosis and treatment of community-acquired pneumonia, from the time of signs and symptoms through treatment with antibiotics and follow-up chest imaging. They were published by a multidisciplinary team, including Dr. Joshua Metlay, PhD, chief of internal medicine at Massachusetts General Hospital (American Journal of Respiratory and Critical Care Medicine, October 1, 2019, Vol. 200:7, pp. e45-e65).
October 2, 2019
Accelerate's PhenoTest BC kit gets CE Mark
The new kit allows antimicrobial testing for the combination treatments ceftazidime-avibactam and ceftolozane-tazobactam for Enterobacteriaceae and Pseudomonas aeruginosa bacteria and trimethoprim-sulfamethoxazole for Acinetobacter baumannii.
August 1, 2019
T2Bacteria panel proves itself, but will hospitals buy in?
The prospective study of 1,427 patients in 11 centers tested the sensitivity, specificity, and speed of the T2Bacteria panel, which is an insert for T2 Biosystems' T2Dx miniaturized magnetic resonance instrument. The system directly tests blood for five types of bacteria ("ESKAPE pathogens") that cause bloodstream infections (BSI): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli.
May 13, 2019
Page 1 of 1